Houston patients living with ankylosing spondylitis (AS) may be eligible to participate in a research program at Advanced Rheumatology that is evaluating treatment options for this chronic inflammatory condition. The program is designed for individuals who have been diagnosed with ankylosing spondylitis and may meet specific study criteria related to their symptoms, disease activity, treatment history, and overall health. Patients who are interested can complete a screening process to determine whether they qualify for participation.
For many people with AS, research studies provide an opportunity to explore emerging treatment options while contributing to the development of future therapies. The first step is determining eligibility. Advanced Rheumatology’s research team reviews each prospective participant individually to see whether they meet the requirements of an active study and whether enrollment may be appropriate for their situation.
Who May Qualify for the Ankylosing Spondylitis Research Program?
At Advanced Rheumatology, eligibility is determined through an individualized screening process rather than a simple online checklist. A patient’s medical history, diagnosis, current symptoms, and treatment background are reviewed to determine whether they may qualify for an available research opportunity.
You may be a candidate if you:
- Have been diagnosed with Ankylosing Spondylitis
- Are 18 years of age or older
- Are currently experiencing back pain or stiffness
- Live in the Houston or greater The Woodlands area
- Are not currently enrolled in another clinical study
Potential Benefits and Considerations of Participation
Research participation offers potential advantages, but it is important for patients to understand both the opportunities and the responsibilities involved.
One potential benefit is access to investigational therapies that are not yet widely available. Clinical trials may also provide additional physician interaction, regular monitoring, and detailed assessments that help track disease activity over time. Participation contributes to medical knowledge that may improve treatment options for future patients with ankylosing spondylitis.
At the same time, research studies involve commitments. Participants may need to attend scheduled appointments, complete questionnaires, undergo testing, or follow specific treatment protocols. Investigational therapies may also have unknown risks or side effects that are still being evaluated. These factors are discussed during the informed consent process before enrollment.
The decision to participate should always be made after discussing potential benefits, risks, and expectations with qualified healthcare professionals and the research team.
Meet the Doctor
Dr. Tamar Brionez brings more than a decade of experience diagnosing and treating rheumatic musculoskeletal diseases and systemic autoimmune disorders. She is recognized for her patient-centered approach and expertise in identifying complex and often challenging conditions.
Committed to delivering exceptional care, Dr. Brionez combines evidence-based medicine with advanced diagnostic tools and the latest clinical research. Her comprehensive, whole-person approach to healthcare has established her as a trusted specialist in the management of complex autoimmune and rheumatic diseases.
Taking the Next Step
If you are interested in participating, the first step is to complete a brief screening with Advanced Rheumatology’s research team. They will review your medical history, symptoms, and diagnosis to determine whether you may qualify for a current ankylosing spondylitis study.
If you appear eligible, the team will explain the study in detail, answer your questions, and conduct any additional evaluations needed to confirm eligibility. Patients who qualify can then decide whether to enroll after completing the informed consent process.
For Houston-area patients living with ankylosing spondylitis, reaching out to the research team is the best way to learn about available research opportunities and determine whether participation may be right for you.
Take a moment to complete this form and we’ll reach out to you with the next steps.
Frequently Asked Questions
How do I know if I qualify for the ankylosing spondylitis research program?
The only way to know for sure is to complete the screening process. Eligibility depends on factors such as your diagnosis, symptoms, treatment history, disease activity, and overall health. The research team reviews this information to determine whether you meet the requirements of a current study.
Do I need a referral to participate?
Not necessarily. Research programs often allow interested patients to contact the study team directly to learn more about eligibility requirements. The screening process will determine whether additional medical information is needed.
What happens during the screening process?
Screening typically involves reviewing your medical history, diagnosis, symptoms, current medications, and previous treatments. Researchers may also review imaging studies, laboratory results, or other records to determine whether you qualify for enrollment.
Can I participate if I am already receiving treatment for ankylosing spondylitis?
Possibly. Many ankylosing spondylitis studies include participants who are currently receiving treatment. Eligibility depends on the specific study requirements and your treatment history.
Is participation in a research study voluntary?
Yes. Participation is completely voluntary. Before enrolling, patients receive detailed information about the study and can decide whether they wish to participate.
What if I do not qualify for the current study?
Not qualifying for one study does not necessarily mean you will not qualify for future research opportunities. Eligibility requirements vary between studies, and new research programs may become available over time.
